Julie Vatté, PhD

RESEARCH SCIENTIST

Dr. Julie Vatté is a Research Scientist at Thryv Therapeutics, where she plays a key role in the design and synthesis of a novel library of SGK1 inhibitors. Previously, she worked as an Organic Chemist at C/D/N Isotopes (LGC Standard), a global leader in the production of deuterium-labeled compounds.

Dr. Vatté holds a degree in Chemical Engineering from CPE Lyon in France. She completed her Ph.D. in Organic Chemistry at Université de Montréal in Canada, where her research focused on developing dual inhibitors targeting the energy metabolism of cancer cells. Additionally, she designed bifunctional molecules, such as PROTACs and AUTACs, aimed at facilitating protein degradation and autophagy.